Status:
UNKNOWN
EEG Objectification in Neuropsychiatry
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Personality Disorder
Depression
Eligibility:
All Genders
15-90 years
Phase:
NA
Brief Summary
The main objective of the study is to evaluate the use of EEG in the management and follow-up of neuropsychiatric disorders. Secondary objectives are therefore better understanding of the pathological...
Detailed Description
Patients are having EEG recordings as a routine part of their clinical evaluation and diagnosis. EEG recording is harmless, has no side effects, any radiation or any mechanical or electrical influence...
Eligibility Criteria
Inclusion
- diagnosis of the investigated neuropsychiatric disease
Exclusion
- Other co-existing neuropsychiatric conditions
- Refusal to participate in the study
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01476228
Start Date
November 1 2011
End Date
December 1 2015
Last Update
November 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HMO
Jerusalem, Israel, 91120